Viking Therapeutics (VKTX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to -$705.7 million.
- Viking Therapeutics' Enterprise Value rose 2181.15% to -$705.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$705.7 million, marking a year-over-year increase of 2181.15%. This contributed to the annual value of -$705.7 million for FY2025, which is 2181.15% up from last year.
- According to the latest figures from Q4 2025, Viking Therapeutics' Enterprise Value is -$705.7 million, which was up 2181.15% from -$714.6 million recorded in Q3 2025.
- In the past 5 years, Viking Therapeutics' Enterprise Value registered a high of -$135.7 million during Q1 2023, and its lowest value of -$963.0 million during Q1 2024.
- Moreover, its 5-year median value for Enterprise Value was -$369.2 million (2023), whereas its average is -$497.0 million.
- As far as peak fluctuations go, Viking Therapeutics' Enterprise Value soared by 6135.48% in 2023, and later crashed by 60982.43% in 2024.
- Over the past 5 years, Viking Therapeutics' Enterprise Value (Quarter) stood at -$202.1 million in 2021, then grew by 23.07% to -$155.5 million in 2022, then crashed by 132.87% to -$362.1 million in 2023, then tumbled by 149.29% to -$902.6 million in 2024, then grew by 21.81% to -$705.7 million in 2025.
- Its Enterprise Value was -$705.7 million in Q4 2025, compared to -$714.6 million in Q3 2025 and -$807.7 million in Q2 2025.